Finance

Lists
Why is CTX down 2,29%?
Dive Deeper
CTX:WSE
Captor Therapeutics SA
64,00 PLN
-2,29%
(-1,50) 1D
9 қаз., 17:00:00 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
65,40 PLN
High
66,70 PLN
Low
62,50 PLN
Mkt. cap
406,62 млн
Avg. vol.
3,27 мың
Volume
10,03 мың
52-wk high
89,20 PLN
52-wk low
37,70 PLN
EPS
-7,77 PLN
Shares outstanding
6,35 млн
No. of employees
82
Open
65,40 PLN
High
66,70 PLN
Low
62,50 PLN
Mkt. cap
406,62 млн
Avg. vol.
3,27 мың
Volume
10,03 мың
52-wk high
89,20 PLN
52-wk low
37,70 PLN
EPS
-7,77 PLN
Shares outstanding
6,35 млн
No. of employees
82
News stories
From web sources and news partners
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
Sector-
Last report
2026 ж. 15 қыр.
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
1,63 млн / 1,50 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
44,00 мың
328,00 м.
1,63 млн
Cost of goods sold
-2,02 млн
-
-
173,00 м.
Cost of revenue
-2,02 млн
-
-
173,00 м.
Research and development expenses
14,74 млн
9,82 млн
10,56 млн
13,78 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 млн
2,53 млн
1,92 млн
2,25 млн
Operating expense
13,83 млн
10,40 млн
11,59 млн
14,39 млн
Total operating expenses
11,81 млн
10,40 млн
11,59 млн
14,56 млн
Operating income
-11,81 млн
-10,36 млн
-11,26 млн
-12,93 млн
Other non operating income
1,00 мың
-8,00 мың
-
-
EBT including unusual items
-11,48 млн
-10,05 млн
-11,35 млн
-11,39 млн
EBT excluding unusual items
-11,48 млн
-10,12 млн
-11,35 млн
-11,39 млн
Income tax expense
-
-
27,00 мың
-
Effective tax rate
-
-
-0,24%
-
Other operating expenses
-2,27 млн
-1,94 млн
-893,00 м.
-1,64 млн
Net income
-11,48 млн
-10,05 млн
-11,38 млн
-11,39 млн
Net profit margin
-
-22 831,82%
-3 467,99%
-696,88%
Earnings per share
-
-
-
-
Interest and investment income
391,00 м.
303,00 м.
39,00 мың
1,63 млн
Interest expense
-61,00 мың
-75,00 мың
-67,00 мың
-57,00 мың
Net interest expenses
330,00 м.
228,00 м.
-28,00 мың
1,57 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,81 млн
-9,53 млн
-10,36 млн
-12,04 млн
Gain or loss from assets sale
-682,00 м.
-
-
-128,00 м.
AI content may include mistakes. Learn more
Google қолданбалары